论文部分内容阅读
AIM To determine whether S-1 induces hepatic steatosis in patients being treated for pancreatic cancer.METHODS This retrospective study evaluated 22 patients who received oral S-1 as a first-line treatment for pancreatic cancer between January 2008 and Ju